Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_assertion type Assertion NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_head.
- NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_assertion description "[We studied systemic prostaglandin E2 (PGE2) metabolism, the levels of soluble CD163 (sCD163) in serum (a marker of monocyte/macrophage activation), and COX-2 -765G>C polymorphism in patients with stable CAD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_provenance.
- NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_assertion evidence source_evidence_literature NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_provenance.
- NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_assertion SIO_000772 20332714 NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_provenance.
- NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_assertion wasDerivedFrom befree-20140225 NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_provenance.
- NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_assertion wasGeneratedBy ECO_0000203 NP928053.RAkzsxl-1mVsDbW-AGQtMfFA70o3VFk9lW7Pbz57l-jJk130_provenance.